70
DARITHANA
B. Markhayeva, doctor of economic sciences, professor
C.
On July 13, 2013 Serik Junn, the CFO of Darithana (“The Company”) had received an official request
from Future bank of Kazakhstan (“The Bank”) for the immediate repayment of all amounts due under
the loan agreement. Darithana was a listed company of generic and branded drugs in Kazakhstan,
Eurasia. Its domestic market share was more than 50% among Kazakhstan’s manufacturers.
The basic terms of the loan agreement were:
(1) the loan would be used to replenish current assets;
(2) the maturity date would come after one year with an annual interest rate of 6.75 %;
(3) the loan collateral was required to maintain the Current Ratio of not less than 1.5.
However, by the beginning of July 2013 this ratio had dropped to 1.28. This gave the Bank the right to
demand repayment of the loan. But the Company currently did not have sufficient funds to meet its
urgent obligation to the Bank.
The same evening, Serik was unpleasantly surprised by a National Broadcasting Company’s
report that
Darithana’s staff had not been paid in full during the last few months. In fact, the Company incurred
debt for its employees’ wages which it tried to keep a secret. This report would have a negative impact
on Darithana’s business image and its relations with investors. Moreover, it would also attract the
attention of the government’s health and safety inspectors.
The Company’s liquidity problems had been linked to the implementation
of a major investment pro-
ject which cost $66 million over a five year period. The project included (1) construction of a new am-
poule factory and (2) the transfer of all production capacities to a standard of “Good Manufacturing
Practice”.
The next day, Serik had looked at the Company’s balance
sheet again, focusing on the short-term assets
and liabilities. He was interested in the financial data at the time of the loan (01/07/2012) and the time
of the Bank’s requirement to return the entire debt (01/07/2013). Below was what he saw:
$000
01/07/2012 01/07/2013
Cash and cash equivalents
9 298
4 630
Trade and other accounts receivables
16 081
24 649
Inventories
21 968
27 283
Other current assets
3 275
3 141
Total current assets (1)
50 622
59 703
Current portion
of long term loans
-
22 172
Short-term loans
14 403
8
Trade and other payables
13 448
19 550
Liabilities under other mandatory and voluntary payments
23
-
Employee benefit liabilities
-
50
Tax liabilities
43
-
Other current liabilities
1 930
4 693
Total current liabilities (2)
29 847
46 473
Current Ratio (1) / (2)
1.69
1.28
Достарыңызбен бөлісу: